Astro Pak launches decontamination services subsidiary
Astro Pak Corporation, a US precision cleaning company, has launched a subsidiary, SixLog, to provide on-site biological decontamination services using proprietary iHP (ionised hydrogen peroxide) technology to the life sciences, pharmaceutical and healthcare industries.
SixLog, headquartered in Santa Ana, California, performs decontamination services for equipment, rooms, entire buildings and modes of transport such as ambulances, trains and cruise ships.
The iHP bio decontamination technology was developed for military applications and this will be the first time that it will be used in commercial applications.
The company says technology can be used in open air and, once ionised, it acts like a gas as opposed to a vapour, providing excellent distribution properties and destroying micro-organisms even in hard-to-reach areas.
Steve Feinstein, formerly regional sales manager of a UK manufacturer of hydrogen peroxide vapour generators, has been appointed as SixLog's director of technology.
In addition to the company launch, SixLog has developed a website containing technical papers, presentations, and other downloads on biological decontamination and sterilisation.
You may also like
Trending Articles
You may also like
Hi Tech Manufacturing
CiP white paper: Photon based gravimetry for high throughput tablet weighing: A technical assessment
Author: Phillip Ruda. "This research was predicated on a late-night conversation between two friends. The kind of 'what-if' question which seems so bonkers you feel compelled to discover by what orders of magnitude it is completely off-the-wall in an attempt to discover a useful grain of truth somewhere in process. My apologies to the real scientists who very serious models we attempted to use to prove or disprove crazy theory. We thought it just about daft enough to share. Enjoy."
Finance
Agarose Bead Technologies marks 25 years with $10m global expansion plan
The Spanish agarose resin specialist will expand into the US and India, invest in scalable bioprocessing technologies and enhance sustainability across its European facilities to meet growing demand for advanced therapy purification
Packaging
Sharp Services invests $100m to expand global sterile and packaging capacity across US and Europe
The investment will boost sterile fill/finish, injectable packaging and oral solid dose capacity across Sharp's US and European sites, strengthening its clinical and commercial manufacturing network to meet growing pharmaceutical demand
Finance
MilliporeSigma to acquire JSR Life Sciences’ chromatography business, boosting Protein A purification capabilities
The acquisition expands MilliporeSigma’s downstream bioprocessing portfolio with JSR’s Amsphere Protein A resin technology, enhancing efficiency and reliability in monoclonal antibody and therapeutic protein production